Clinical Trial Update: Comparison Of Reduced DAPT Followed by P2Y12 Inhibitor Monotherapy With Prasugrel vs stAndard Regimen in STEMI Patients [Phase 4]

View source ↗

Summary

Phase 4 trial investigating reduced dual antiplatelet therapy followed by prasugrel monotherapy versus standard regimen in patients presenting with ST-elevation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• PRASUGREL (prasugrel)

Snippet

Sponsor: Research Maatschap Cardiologen Rotterdam Zuid | Conditions: ST Elevated Myocardial Infarction, Dual Antiplatelet Therapy | Phase 4 | Status: RECRUITING